Rachel C. Steinhardt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rachel C. Steinhardt has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Aaron P. Esser-Kahn
University of Chicago
5 shared publications Spencer T. Kim
Syracuse University, Syracuse, New York 13244, United States
5 shared publicationsEmma J. Doukmak
Syracuse University, Syracuse, New York 13244, United States
3 shared publicationsJasmine C. Gomez
Syracuse University 111 College Place Syracuse NY 13244 USA
3 shared publicationsDylan J. Gray
Syracuse University, Syracuse, New York 13244, United States
2 shared publicationsEbbing de Jong
SUNY Upstate Medical University, Syracuse, New York 13244, United States
2 shared publications
Latest Publications
- 12 May 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (10) , 12690-12701
Redefining Drug Immune Recognition: A Radically Reconfigured Molecular Architecture Enables Broad Fentanyl-Class Protection
Synthetic opioids pose a chemically evolvable threat, in which extreme potency and rapid diversification allow fentanyl analogues to outpace structure-specific countermeasures. Immune strategies largely responded by copying the parent chemotype, implicitly treating small-molecule recognition as scaffold-dependent. Here, we examined an alternative hypothesis: adaptive immunity can recover fentanyl-class identity from transferable spatial and physicochemical information. Replacing the canonical piperidine of fentanyl with a 2-azaspiro[3.3]heptane, we created a chemically orthogonal immunogen with a radically altered three-dimensional arrangement. Despite this, vaccination elicited high-titer cross-reactive antibodies, broad fentanyl-analogue binding, and protection matching a fentanyl-derived benchmark. Fentanyl antinociception shifted into the ∼1.1-2.1 mg kg-1 range, preserved ventilation during respiratory challenge, and reduced brain fentanyl from 61.9 ± 10.0 to 17.2 ± 0.7 nM. These results reveal programmable antibody recognition, demonstrating that molecular class identity arises not from direct structural mimicry but through higher-order spatial and physicochemical relationships.
- 12 May 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (10) , 12690-12701
Redefining Drug Immune Recognition: A Radically Reconfigured Molecular Architecture Enables Broad Fentanyl-Class Protection
Synthetic opioids pose a chemically evolvable threat, in which extreme potency and rapid diversification allow fentanyl analogues to outpace structure-specific countermeasures. Immune strategies largely responded by copying the parent chemotype, implicitly treating small-molecule recognition as scaffold-dependent. Here, we examined an alternative hypothesis: adaptive immunity can recover fentanyl-class identity from transferable spatial and physicochemical information. Replacing the canonical piperidine of fentanyl with a 2-azaspiro[3.3]heptane, we created a chemically orthogonal immunogen with a radically altered three-dimensional arrangement. Despite this, vaccination elicited high-titer cross-reactive antibodies, broad fentanyl-analogue binding, and protection matching a fentanyl-derived benchmark. Fentanyl antinociception shifted into the ∼1.1-2.1 mg kg-1 range, preserved ventilation during respiratory challenge, and reduced brain fentanyl from 61.9 ± 10.0 to 17.2 ± 0.7 nM. These results reveal programmable antibody recognition, demonstrating that molecular class identity arises not from direct structural mimicry but through higher-order spatial and physicochemical relationships.
- Open Access
- 26 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Synthesis of carbamates using Cs2CO3 as the CO2 source: Facile synthesis of solifenacin
We are reporting on a new method to synthesize carbamates. The most common way to access carbamates from an amine is through the use of alkyl chloroformate. We have used alkyl p-toluenesulfonate and metal carbonate to access the carbamate from an amine. We hypothesized that the carbon dioxide needed to form the carbamate would come from the metal carbonate. We systematically tried a number of variations with the starting materials and reaction conditions, and got to the maximum yield of 85%. We have also mapped out the scope of this reaction. As a representative case, we have synthesized (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester, an intermediate in the synthesis of solifenacin (a common drug for overactive bladder), from (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline, with an overall yield of 69%. This alternative method of carbamate synthesis is new and efficient.
- 26 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessSynthesis of carbamates using Cs2CO3 as the CO2 source: Facile synthesis of solifenacin
We are reporting on a new method to synthesize carbamates. The most common way to access carbamates from an amine is through the use of alkyl chloroformate. We have used alkyl p-toluenesulfonate and metal carbonate to access the carbamate from an amine. We hypothesized that the carbon dioxide needed to form the carbamate would come from the metal carbonate. We systematically tried a number of variations with the starting materials and reaction conditions, and got to the maximum yield of 85%. We have also mapped out the scope of this reaction. As a representative case, we have synthesized (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester, an intermediate in the synthesis of solifenacin (a common drug for overactive bladder), from (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline, with an overall yield of 69%. This alternative method of carbamate synthesis is new and efficient.
- Open Access
- 25 September 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (83) , 11956-11959
Photoswitchable TCB-2 for control of the 5-HT 2A receptor and analysis of biased agonism
Therapies that target the serotonin 2A receptor (5-HT 2A R) are promising. However, probes are needed to better understand the role of 5-HT 2A R.
- 25 September 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (83) , 11956-11959
Open AccessPhotoswitchable TCB-2 for control of the 5-HT 2A receptor and analysis of biased agonism
Therapies that target the serotonin 2A receptor (5-HT 2A R) are promising. However, probes are needed to better understand the role of 5-HT 2A R.
- Open Access
- 18 September 2023
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 14 (19) , 3665-3673
Photoactivatable Agonist–Antagonist Pair as a Tool for Precise Spatiotemporal Control of Serotonin Receptor 2C Signaling
Orthogonal recreation of the signaling profile of a chemical synapse is a current challenge in neuroscience. This is due in part to the kinetics of synaptic signaling, where neurotransmitters are rapidly released and quickly cleared by active reuptake machinery. One strategy to produce a rapid rise in an orthogonally controlled signal is via photocaged compounds. In this work, photocaged compounds are employed to recreate both the rapid rise and equally rapid fall in activation at a chemical synapse. Specifically, a complementary pair of photocages based on BODIPY were conjugated to a 5-HT2C subtype-selective agonist, WAY-161503, and antagonist, N-desmethylclozapine, to generate "caged" versions of these drugs. These conjugates release the bioactive drug upon illumination with green light (agonist) or red light (antagonist). We report on the synthesis, characterization, and bioactivity testing of the conjugates against the 5-HT2C receptor. We then characterize the kinetics of photolysis quantitatively using HPLC and qualitatively in cell culture conditions stimulating live cells. The compounds are shown to be stable in the dark for 48 h at room temperature, yet photolyze rapidly when irradiated with visible light. In live cells expressing the 5-HT2C receptor, precise spatiotemporal control of the degree and length of calcium signaling is demonstrated. By loading both compounds in tandem and leveraging spectral multiplexing as a noninvasive method to control local small-molecule drug availability, we can reproducibly initiate and suppress intracellular calcium flux on a timescale not possible by traditional methods of drug dosing. These tools enable a greater spatiotemporal control of 5-HT2C modulation and will allow for more detailed studies of the receptors' signaling, interactions with other proteins, and native physiology.
- 18 September 2023
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 14 (19) , 3665-3673
Open AccessPhotoactivatable Agonist–Antagonist Pair as a Tool for Precise Spatiotemporal Control of Serotonin Receptor 2C Signaling
Orthogonal recreation of the signaling profile of a chemical synapse is a current challenge in neuroscience. This is due in part to the kinetics of synaptic signaling, where neurotransmitters are rapidly released and quickly cleared by active reuptake machinery. One strategy to produce a rapid rise in an orthogonally controlled signal is via photocaged compounds. In this work, photocaged compounds are employed to recreate both the rapid rise and equally rapid fall in activation at a chemical synapse. Specifically, a complementary pair of photocages based on BODIPY were conjugated to a 5-HT2C subtype-selective agonist, WAY-161503, and antagonist, N-desmethylclozapine, to generate "caged" versions of these drugs. These conjugates release the bioactive drug upon illumination with green light (agonist) or red light (antagonist). We report on the synthesis, characterization, and bioactivity testing of the conjugates against the 5-HT2C receptor. We then characterize the kinetics of photolysis quantitatively using HPLC and qualitatively in cell culture conditions stimulating live cells. The compounds are shown to be stable in the dark for 48 h at room temperature, yet photolyze rapidly when irradiated with visible light. In live cells expressing the 5-HT2C receptor, precise spatiotemporal control of the degree and length of calcium signaling is demonstrated. By loading both compounds in tandem and leveraging spectral multiplexing as a noninvasive method to control local small-molecule drug availability, we can reproducibly initiate and suppress intracellular calcium flux on a timescale not possible by traditional methods of drug dosing. These tools enable a greater spatiotemporal control of 5-HT2C modulation and will allow for more detailed studies of the receptors' signaling, interactions with other proteins, and native physiology.
- 21 March 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (24)
Robotic Locomotion and Piezo1 Activity Controlled with Novel Liquid Marble‐based Soft Actuators
A novel soft actuator is designed, fabricated, and optimized for applied use in soft robotics and biomedical applications. The soft actuator is powered by the expansion and contraction of a graphene‐containing and encased liquid marble using the photothermal effect. Unfortunately, conventional liquid marbles are found to be too fragile and prone to cracking and failure for such applications. After experimentation, it is possible to remedy this problem by synthesizing liquid marbles encased with polymeric shells–polymerized in situ–for added mechanical strength and robustness. These marbles are shown to have intrinsic photothermal activity. They are then situated in bimorph‐type soft actuators where one side of the actuator has a dramatically different Young's modulus than the other, leading to directional actuation which is successfully demonstrated in multistep walking soft robots. The soft actuators are shown to successfully activate the mechanosensitive Piezo protein in a transfected human cell line with high effectiveness and no toxicity. Overall, the liquid marble‐powered soft actuators described here represent a new soft actuation methodology and a novel tool for mechanobiological studies, such as stem cell fate and organoid differentiation.
- 21 March 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (24)
Robotic Locomotion and Piezo1 Activity Controlled with Novel Liquid Marble‐based Soft Actuators
A novel soft actuator is designed, fabricated, and optimized for applied use in soft robotics and biomedical applications. The soft actuator is powered by the expansion and contraction of a graphene‐containing and encased liquid marble using the photothermal effect. Unfortunately, conventional liquid marbles are found to be too fragile and prone to cracking and failure for such applications. After experimentation, it is possible to remedy this problem by synthesizing liquid marbles encased with polymeric shells–polymerized in situ–for added mechanical strength and robustness. These marbles are shown to have intrinsic photothermal activity. They are then situated in bimorph‐type soft actuators where one side of the actuator has a dramatically different Young's modulus than the other, leading to directional actuation which is successfully demonstrated in multistep walking soft robots. The soft actuators are shown to successfully activate the mechanosensitive Piezo protein in a transfected human cell line with high effectiveness and no toxicity. Overall, the liquid marble‐powered soft actuators described here represent a new soft actuation methodology and a novel tool for mechanobiological studies, such as stem cell fate and organoid differentiation.
- Open Access
- 30 December 2022
- Published by American Chemical Society (ACS) in ChemRxiv
Photoactivable WAY-161503 and Desmethylclozapine for Tight Regulation of Serotonin Receptor 2C Signaling.
Recreating the signaling profile a chemical synapse to analyze serotonin receptor activation is a challenge. This is due in part to the kinetics of the synapse, where neurotransmitters are rapidly released and quickly cleared by active reuptake machinery. One strategy to produce a rapid rise in a bio-orthogonally controlled signal is via photocaged compounds. In this work, a complementary pair of BODIPY photoremovable protecting groups was conjugated to a 5HT2C subtype selective agonist, WAY-161503, and antagonist, N-desmethylclozapine, to generate “caged” versions of these drugs. These conjugates can release their bioactive drug upon stimulation with green light (agonist) or red light (antagonist). We report on the synthesis, characterization, and bioactivity testing of the conjugates against the 5HT2C receptor. We then characterize the kinetics of photolysis quantitatively using HPLC and qualitatively in cell culture conditions stimulating live cells. The compounds are shown to be stable under dark conditions for 48 hours at room temperature, yet photolyze readily when irradiated with visible light. In live cells expressing the 5HT2C receptor, precise spatiotemporal control of the degree and length of calcium signaling is demonstrated. By loading both compounds in tandem and leveraging spectral multiplexing as a non-invasive method to control local small molecule drug availability, we can reproducibly initiate and suppress intracellular calcium flux on a timescale not possible by traditional methods of drug dosing. These tools enable a greater spatiotemporal control of 5HT2C modulation and will allow for more detailed studies of the receptors signaling, interactions with other proteins, and native physiology.
- 30 December 2022
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessPhotoactivable WAY-161503 and Desmethylclozapine for Tight Regulation of Serotonin Receptor 2C Signaling.
Recreating the signaling profile a chemical synapse to analyze serotonin receptor activation is a challenge. This is due in part to the kinetics of the synapse, where neurotransmitters are rapidly released and quickly cleared by active reuptake machinery. One strategy to produce a rapid rise in a bio-orthogonally controlled signal is via photocaged compounds. In this work, a complementary pair of BODIPY photoremovable protecting groups was conjugated to a 5HT2C subtype selective agonist, WAY-161503, and antagonist, N-desmethylclozapine, to generate “caged” versions of these drugs. These conjugates can release their bioactive drug upon stimulation with green light (agonist) or red light (antagonist). We report on the synthesis, characterization, and bioactivity testing of the conjugates against the 5HT2C receptor. We then characterize the kinetics of photolysis quantitatively using HPLC and qualitatively in cell culture conditions stimulating live cells. The compounds are shown to be stable under dark conditions for 48 hours at room temperature, yet photolyze readily when irradiated with visible light. In live cells expressing the 5HT2C receptor, precise spatiotemporal control of the degree and length of calcium signaling is demonstrated. By loading both compounds in tandem and leveraging spectral multiplexing as a non-invasive method to control local small molecule drug availability, we can reproducibly initiate and suppress intracellular calcium flux on a timescale not possible by traditional methods of drug dosing. These tools enable a greater spatiotemporal control of 5HT2C modulation and will allow for more detailed studies of the receptors signaling, interactions with other proteins, and native physiology.
- Open Access
- 24 November 2022
- Published by American Chemical Society (ACS) in ChemRxiv
Near-IR actuator bimorphs: soft robot locomotion and Piezo protein activation
A novel soft actuator is designed, fabricated, and optimized from liquid marbles encased via interfacial polymerization for added mechanical strength and robustness. They are encased in bimorph-type soft actuators where one side of the actuator has a dramatically different Young’s modulus than the other, leading to directional actuation which is successfully demonstrated in multistep walking soft robots. The soft actuators were also shown to successfully activate the mechanosensitive Piezo protein in a transfected human cell line, 293T. Overall, the liquid marble powered soft actuators described here represent a new soft actuation methodology and a novel tool for mechanobiological studies.
- 24 November 2022
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessNear-IR actuator bimorphs: soft robot locomotion and Piezo protein activation
A novel soft actuator is designed, fabricated, and optimized from liquid marbles encased via interfacial polymerization for added mechanical strength and robustness. They are encased in bimorph-type soft actuators where one side of the actuator has a dramatically different Young’s modulus than the other, leading to directional actuation which is successfully demonstrated in multistep walking soft robots. The soft actuators were also shown to successfully activate the mechanosensitive Piezo protein in a transfected human cell line, 293T. Overall, the liquid marble powered soft actuators described here represent a new soft actuation methodology and a novel tool for mechanobiological studies.
- Open Access
- 2 October 2022
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 13 (20) , 3008-3022
Developing Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson’s Disease Drugs
Dopaminergic pathways control highly consequential aspects of physiology and behavior. One of the most therapeutically important and best-studied receptors in these pathways is dopamine receptor D2 (DRD2). Unfortunately, DRD2 is challenging to study with traditional molecular biological techniques, and most drugs designed to target DRD2 are ligands for many other receptors. Here, we developed probes able to both covalently bind to DRD2 using photoaffinity labeling and provide a chemical handle for detection or affinity purification. These probes behaved like good DRD2 agonists in traditional biochemical assays and were able to perform in chemical-biological assays of cell and receptor labeling. Rat whole brain labeling and affinity enrichment using the probes permitted proteomic analysis of the probes' interacting proteins. Bioinformatic study of the hits revealed that the probes bound noncanonically targeted proteins in Parkinson's disease network as well as the retrograde endocannabinoid signaling, neuronal nitric oxide synthase, muscarinic acetylcholine receptor M1, GABA receptor, and dopamine receptor D1 (DRD1) signaling networks. Follow-up analysis may yield insights into how this pathway relates specifically to Parkinson's disease symptoms or provide new targets for treatments. This work reinforces the notion that the combination of chemical biology and omics-based approaches provides a broad picture of a molecule's "interactome" and may also give insight into the pleiotropy of effects observed for a drug or perhaps indicate new applications.
- 2 October 2022
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 13 (20) , 3008-3022
Open AccessDeveloping Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson’s Disease Drugs
Dopaminergic pathways control highly consequential aspects of physiology and behavior. One of the most therapeutically important and best-studied receptors in these pathways is dopamine receptor D2 (DRD2). Unfortunately, DRD2 is challenging to study with traditional molecular biological techniques, and most drugs designed to target DRD2 are ligands for many other receptors. Here, we developed probes able to both covalently bind to DRD2 using photoaffinity labeling and provide a chemical handle for detection or affinity purification. These probes behaved like good DRD2 agonists in traditional biochemical assays and were able to perform in chemical-biological assays of cell and receptor labeling. Rat whole brain labeling and affinity enrichment using the probes permitted proteomic analysis of the probes' interacting proteins. Bioinformatic study of the hits revealed that the probes bound noncanonically targeted proteins in Parkinson's disease network as well as the retrograde endocannabinoid signaling, neuronal nitric oxide synthase, muscarinic acetylcholine receptor M1, GABA receptor, and dopamine receptor D1 (DRD1) signaling networks. Follow-up analysis may yield insights into how this pathway relates specifically to Parkinson's disease symptoms or provide new targets for treatments. This work reinforces the notion that the combination of chemical biology and omics-based approaches provides a broad picture of a molecule's "interactome" and may also give insight into the pleiotropy of effects observed for a drug or perhaps indicate new applications.
- Open Access
- 21 July 2022
- Published by American Chemical Society (ACS) in ChemRxiv
Developing Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson’s Disease Drugs
Dopaminergic pathways control highly consequential aspects of physiology and behavior. One of the most therapeutically important and best-studied receptors in these pathways is dopamine receptor D2 (DRD2). Unfortunately, DRD2 is challenging to study with traditional molecular biological techniques, and most drugs designed to target DRD2 are ligands for many other receptors. Here, we developed probes able to both covalently bind to DRD2 using photoaffinity labeling as well as provide a chemical handle for detection or affinity purification. These probes behaved like good DRD2 agonists in traditional biochemical assays and were able to perform in chemical biological assays of cell and receptor labeling. Rat whole brain labeling and affinity enrichment using the probe permitted proteomic analysis of the probes’ interacting proteins. Bioinformatic study of the hits revealed that the probes bound non-canonically targeted proteins in the Parkinson’s disease network as well as the retrograde endocannabinoid signaling, neuronal nitric oxide synthase, muscarinic acetylcholine receptor M1, GABA receptor, and dopamine receptor D1 (DRD1) signaling networks. Follow-up analysis may yield insights into how this pathway relates specifically to Parkinson’s disease symptoms or provide new targets for treatments. This work reinforces the notion that the combination of chemical biology and omics-based approaches provide a broad picture of a molecule’s “interactome,” and may also give insight into the pleiotropy of effects observed for a drug, or perhaps indicate new applications.
- 21 July 2022
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDeveloping Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson’s Disease Drugs
Dopaminergic pathways control highly consequential aspects of physiology and behavior. One of the most therapeutically important and best-studied receptors in these pathways is dopamine receptor D2 (DRD2). Unfortunately, DRD2 is challenging to study with traditional molecular biological techniques, and most drugs designed to target DRD2 are ligands for many other receptors. Here, we developed probes able to both covalently bind to DRD2 using photoaffinity labeling as well as provide a chemical handle for detection or affinity purification. These probes behaved like good DRD2 agonists in traditional biochemical assays and were able to perform in chemical biological assays of cell and receptor labeling. Rat whole brain labeling and affinity enrichment using the probe permitted proteomic analysis of the probes’ interacting proteins. Bioinformatic study of the hits revealed that the probes bound non-canonically targeted proteins in the Parkinson’s disease network as well as the retrograde endocannabinoid signaling, neuronal nitric oxide synthase, muscarinic acetylcholine receptor M1, GABA receptor, and dopamine receptor D1 (DRD1) signaling networks. Follow-up analysis may yield insights into how this pathway relates specifically to Parkinson’s disease symptoms or provide new targets for treatments. This work reinforces the notion that the combination of chemical biology and omics-based approaches provide a broad picture of a molecule’s “interactome,” and may also give insight into the pleiotropy of effects observed for a drug, or perhaps indicate new applications.
- 9 May 2022
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 139 (28)
Thermally expandable microspheres with high expansion ratios: Design of core and shell for largest size change
Thermally expandable microspheres (TEMs) are liquid‐core, polymer‐shelled particles that are useful in both current industry and future manufacturing and basic research applications. Here, we systematically optimize TEMs for highest expansion ratio using a broad‐spectrum infrared head source. Microspheres are synthesized from a copolymer of 2‐hydroxyethyl methacrylate (HEMA), methyl methacrylate, and acrylonitrile as the shell, which is optimized for greatest expansion ratio. This represents the first time that HEMA is used in TEMs. The liquid blowing agent core is next optimized, followed by the prepolymerization emulsion time. It is found that particle morphology is greatly variable and influenced by kinetic and thermodynamic factors, with various phase‐separated and aniosotropic morphologies accessed.
- 9 May 2022
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 139 (28)
Thermally expandable microspheres with high expansion ratios: Design of core and shell for largest size change
Thermally expandable microspheres (TEMs) are liquid‐core, polymer‐shelled particles that are useful in both current industry and future manufacturing and basic research applications. Here, we systematically optimize TEMs for highest expansion ratio using a broad‐spectrum infrared head source. Microspheres are synthesized from a copolymer of 2‐hydroxyethyl methacrylate (HEMA), methyl methacrylate, and acrylonitrile as the shell, which is optimized for greatest expansion ratio. This represents the first time that HEMA is used in TEMs. The liquid blowing agent core is next optimized, followed by the prepolymerization emulsion time. It is found that particle morphology is greatly variable and influenced by kinetic and thermodynamic factors, with various phase‐separated and aniosotropic morphologies accessed.